Source comparison
CJC-1295 for Lean Bulk Peptides Research: Compound Comparison
This table compares CJC-1295 DAC against other peptides commonly evaluated in lean bulk research protocols. CJC-1295 DAC GHRH receptor agonist with albumin binding ~8 days Weekly Sustained GH elevation for lean tissue synthesis studies Best for protocols requi
This comparison does not assign a generated winner or score.
- This table compares CJC-1295 DAC against other peptides commonly evaluated in lean bulk research protocols.
- CJC-1295 DAC
- GHRH receptor agonist with albumin binding
- ~8 days
- Weekly
- Sustained GH elevation for lean tissue synthesis studies
- Best for protocols requiring stable multi-day IGF-1 elevation
- Modified GRF(1-29)
- GHRH receptor agonist without albumin binding
- ~30 minutes
- 2–3× daily
- Pulsatile GH research with precise timing control
- Requires frequent dosing but offers higher peak GH amplitudes
- Ipamorelin
- Ghrelin receptor agonist (GHRP)
- ~2 hours
- GH secretagogue studies with minimal cortisol/prolactin impact
- Synergistic when combined with GHRH agonists
- MK-677 (Ibutamoren)
- Oral ghrelin mimetic
- 24 hours
- Daily (oral)
- Non-injectable GH secretagogue research
- Oral bioavailability but appetite stimulation complicates lean bulk models
- Hexarelin
- ~70 minutes
- High-amplitude GH pulse research
- Strongest GH release but desensitises after 14–21 days